Stocks Actavis Inc

More

  • What follows is a look at stocks in the S&P 500 displaying unusual volume in today's trading session.

  • What follows is a look at stocks in the S&P 500 displaying unusual volume in today's trading session.

  • earnings_central_badge.jpg

    What follows is a roundup of corporate earnings reports for Tuesday, Feb. 23.

  • Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Retail sales, at down 0.3 percent, was below expectations of a gain of 0.5 percent, though November was revised upward, while first time unemployment claims rose slightly more than expected for the week.

  • The Shanghai Index dropped 3.1 percent (Hong Kong down 2.6 percent) as China yesterday raised bank reserve requirements, which amounted to a tightening of monetary policy.

  • Shares of generic drugmaker Mylan dropped for the third straight session yesterday but drew heavy upside options activity.

  • Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Stocks declined Wednesday as weak demand for today's Treasury auction and a sharp drop in oil prices dragged on the market. A disappointing durable-goods report didn't help either.

  • Stocks declined Wednesday after a report showed a much sharper drop in durable-goods orders than expected. Plus, a sharp selloff in China dragged on oil prices, which also weighed on the market.

  • Futures tumbled Wednesday after a report showed a much sharper drop in durable-goods orders than expected. Plus, a sharp selloff in China dragged on oil prices, which also weighed on the market.

  • Following are the day’s biggest winners and losers. Find out why shares of Watson Pharmaceuticals and Netflix popped while KeyCorp and Rio Tinto dropped.

  • The Lightning Round is extended in this CNBC.com exclusive feature.

  • The S&P 500 crossed above its 200-day moving average today for the first time since May 2008.  As upward momentum builds in the markets, the here are fourteen companies that are near new highs.

  • Amid the gloom, Birinyi Associates' Cleve Rueckert found what he sees as a bright spot in the stock market. In a note, he says growth is the place to be, based on performance of the S&P's Pure Growth Index versus the S&P Pure Value Index. Here's his list of 15 stocks in the S&P 500 that fit three key growth criteria.

  • Ritz Carlton Naples

    At the risk of offending our gracious hosts here at the Generic Pharmaceutical Association's Silver Anniversary Meeting, I wanted to talk about the seemingly incongruous venue for the event.

  • Despite the ongoing recession, generic drug makers like Teva Pharmaceutical and Watson Pharmaceutical have been outperforming in the broader market. CEOs William Marth and Paul Bisaro both expect to see further growth.

  • Cramer makes the call on viewers' favorite stocks.

  • graphic_word_ofthe_street.jpg

    Fast Money now – the plays you need while the market is still open

  • Options action on Watson Phamaceuticals indicates that traders think it might be a takeover target, according to one options experts